Skip to content

LifeBridge Innovations

Wearable electric-field therapy for metastatic cancer

Raised to date

$3.4M

of $5M offered across 1 Form D filing

Still open
$1.6M
Investors
64
Last filed
Jul 14, 2026

About

LifeBridge Innovations, PBC is a Longwood, Florida public benefit corporation developing a wearable cancer therapy device for patients with widespread metastatic disease. Its patented LB10000 delivers Adaptive Tumor Treating Fields (ATTF), low-intensity alternating electric fields that disrupt cell division, using a programmable disc array that can dynamically reassign array elements rather than treating a single fixed site. The company states it has an FDA-vetted basket-trial protocol covering up to 14 cancer types in a single study and is preparing animal safety work ahead of a human pilot trial. It is a participant in the University of Central Florida Business Incubation Program and has raised from angel and crowdfunding investors.

Existing tumor treating field systems use static arrays aimed at one tumor site; LifeBridge's programmable, dynamically reassignable disc array is intended to treat diffuse or multi-site metastatic disease so patients are not forced to choose which tumor to treat.

Funding

  • OtherFiled Jul 14, 2026Form D/A
    $3.4M/ $5M

Product

LB10000

Oncology therapy device

A patented wearable device that applies Adaptive Tumor Treating Fields — low-intensity alternating electric fields — through a programmable disc array to interfere with the division of cancer cells across multiple sites in the torso.

  • Programmable disc system with dynamic reassignment of array elements
  • Low-intensity alternating electric fields targeting charged proteins during mitosis
  • Designed for diffuse and multi-site metastatic disease in the torso

Built for

Stage IV cancer patients with metastatic disease at multiple sites, reached through oncologists and cancer treatment centers

People on file